Chesapeake Clinical Research, Inc. | White Marsh, MD

Research site

About

High level, experienced asthma/allergy/immunology site. Extensive experience in asthma, sinusitis, nasal polyposis, allergic rhinitis, eosinophilic disorders, urticaria and atopic dermatitis. We also work on vaccine trials and respiratory viral diseases.

Location

5430 Campbell Boulevard Suite #110, White Marsh, Maryland, United States of America

Site insights

Top conditions

Top treatments

Verekitug

UPB-101

MK-7264

PF-04965842

Gefapixant

Albuterol Sulfate

Fluticasone Propionate

Rocatinlimab

BAY1817080

DUPIXENT®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Jonathan Matz

Verified by this site

Active trials

8 of 32 total trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting

Severe Asthma

Drug: Verekitug

Drug: Placebo

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses i...

Active, not recruiting

Asthma

Drug: Placebo

Drug: AMG 691

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps tr...

Enrolling

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Drug: Standard therapy for INCS

Drug: LY3650150

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Other: Placebo

Drug: Verekitug

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of chronic spontaneou...

Enrolling

Chronic Spontaneous Urticaria

Drug: Placebo - 100 mg

Drug: Ritlecitinib 50 mg

A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of...

Enrolling

Asthma

Other: Placebo

Drug: tilrekimig

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting

Asthma

Drug: TEV-56248

Drug: Albuterol sulfate

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics...

Active, not recruiting

Chronic Inducible Urticaria

Chronic Spontaneous Urticaria

Drug: Placebo

Drug: BLU-808